NSE filing, NSE: CRIZAC. Summary written from the filing by ALFA Finder's alert engine.
Crizac Ltd: key numbers
- Share price
- ₹138.56
- Market cap
- ₹2,425 Cr
- Revenue (annual)
- ₹1,042 Cr
- Net profit (annual)
- ₹219.1 Cr
- P/E (TTM)
- 11.0×Sector 33.8×
- Promoter holding
- 79.94%+0.00% QoQ
- FII holding
- 1.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crizac Ltd
All →Crizac Dividend
Crizac set November 6, 2026 as record date for its FY2026-27 interim dividend of ₹4 per share. Payment completes by November 27, 2026.
Crizac Q2 FY27 Results: Net Profit ₹36.2 Cr, Down 25.1% YoY
Crizac Ltd reported revenue from operations of ₹102.7 Cr (-36.7% YoY) and net profit of ₹36.2 Cr (-25.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹36.2 Cr · -25.1% YoY
Crizac Board Meeting Date
Crizac Ltd intimated a board meeting on October 30, 2026 to approve Q2/H1 results and consider an interim dividend for FY2026-27. Record date is November 6, 2026, subject to board approval.
Crizac Product Launch
Crizac Ltd launched its Partner Growth Program providing marketing, certification and branding to partners. It targets the existing 17,400+ partner network, with no monetary value disclosed.
Crizac Other Announcement
Crizac Limited filed its quarterly compliance certificate under SEBI Regulation 74(5) for the period ended September 30, 2026, as received from its RTA.
Crizac Acquisition Worth ₹12.37 Cr
Crizac revised its Edument Consultancy acquisition after a shareholder withdrew consent. Revised consideration is ₹12.37 Crore for approximately 36.80% stake.
- Value
- ₹12.37 Cr
Other results update announcements
All →Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Acme Universal Safezone 9 Results Update
Acme Universal Safezone 9 reported H1FY27 revenue up 16.09% to ₹119.93 crore. EBITDA rose 54.62% and PAT turned to ₹7.02 crore profit.
Radiowalla Network Results Update
Radiowalla Network reported H1 FY27 revenue of ₹107.93 million, up 7% year-on-year. EBITDA rose to ₹8.16 million, with an 8% margin.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr